Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/25/2022* -- Results Q4 2021 -- -1.09 --
02/25/2022* 10:00 EST Earnings Call Q4 2021 -- -- --
11/04/2021 -- Results Q3 2021 -2.07 0.49 -523.5%
11/04/2021 10:00 EST Earnings Call Q3 2021 -- -- --
08/05/2021 -- Results Q2 2021 -1.90 -1.97 3.43%
08/05/2021 10:00 EST Earnings Call Q2 2021 -- -- --
05/06/2021 -- Results Q1 2021 -2.29 -1.75 -30.67%
05/06/2021 10:00 EST Earnings Call Q1 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 02/25/2022
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 11/04/2021
Beat/Miss Upgrade
Return Since -13.72%
Last FQE 09/30/2021
Next FQE 12/30/2021

Profile

Edit
Albireo Pharma Inc is a biopharmaceutical company. It engages in the research and development of drug reformulation technology. The company product portfolio includes Pediatric Liver, Adult Liver, and Gastrointestinal.
URL http://www.albireopharma.com
Investor Relations URL http://investor.biodel.com/
HQ State/Province Massachusetts
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release Feb. 25, 2022
Last Earnings Release Nov. 04, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-74.24%
72.50%
44.39%
-4.18%
3.63%
47.56%
-37.91%
9.32%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-7.66%
--
--
--
--
-52.93%
-29.46%
58.82%
-13.33%
-87.17%
63.37%
16.67%
-79.93%
-17.17%
8.91%
-45.97%
-19.62%
-9.04%
-23.93%
70.05%
-17.52%
10.42%
-13.60%
-24.30%
-23.18%
-18.25%
-29.46%
-55.16%
-57.46%
-66.95%
321.7%
-47.71%
-19.85%
As of January 21, 2022.

Profile

Edit
Albireo Pharma Inc is a biopharmaceutical company. It engages in the research and development of drug reformulation technology. The company product portfolio includes Pediatric Liver, Adult Liver, and Gastrointestinal.
URL http://www.albireopharma.com
Investor Relations URL http://investor.biodel.com/
HQ State/Province Massachusetts
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release Feb. 25, 2022
Last Earnings Release Nov. 04, 2021
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
WSCIX 116660.0 USD 2.12%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Stocktwits ALBO Tweets